TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Dividend Stocks
Revealed: 3 Dirty Secrets Bay Street Doesn’t Want You to Know
Investing
3 Marijuana Stocks That Could Surprise Everyone in 2019

Investing
Don’t Sell Your Cannabis Investment Just Yet…

Investing
The #1 Marijuana Stock to Watch in 2019

Investing
Is Canopy Growth Corp. (TSX:WEED) Stock a Strong Buy Heading Into 2019?

Investing
Faced With Lawsuits, Could Aphria Inc (TSX:APHA) Still Be a Buy?
Investing
2 Top Pot Stocks to Buy for 2019

Investing
Canopy Growth Corp’s (TSX:WEED) Stock a High Potential Play on U.S. Hemp Growth
Investing
2 Top Marijuana Stocks to Watch in 2019

Investing
Should HEXO Corp. (TSX:HEXO) or Canopy Growth Corp (TSX:WEED) Stock Be on Your 2019 Buy List?

Investing
Ontario Marijuana Store Cutbacks: Will Cannabis Stocks Suffer?
